Faga Daniel
SEC CIK 1673528 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ANAB | ANAPTYSBIO, INC | Pres, CEO, Dir | 510.6K | — | $6.34M | 15 | 2022-03-21 | 2026-03-27 |
Most active insiders at ANAB, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | LOUMEAU ERIC J | CLO | — | $2.98M |
| 2 | Faga Daniel | Pres, CEO, Dir | — | $2.81M |
| 3 | MULROY DENNIS | CFO | — | $1.55M |
| 4 | Schmid John P. | Dir | — | $1.16M |
| 5 | Marquet Magda | Dir | — | $530.6K |
| 6 | Lizzul Paul F. | Chief Medical Off | — | $521.5K |
| 7 | Ware J. Anthony | Dir | — | $193.4K |
| 8 | Orwin John A | Dir | — | — |
| 9 | RENTON HOLLINGS | Dir | — | — |
Transactions 15
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-03-27 | 2026-03-27 | ANAB | ANAPTYSBIO, INC | Faga Daniel | Pres, CEO, Dir | S - Sale | $61.61 | -17.7K | 510.6K | -3% | -$1.09M |
| 2026-03-27 | 2026-03-25 | ANAB | ANAPTYSBIO, INC | Faga Daniel | Pres, CEO, Dir | A - Grant | — | +34.3K | 513.6K | +7% | — | |
| D | 2026-01-09 | 2026-01-07 | ANAB | ANAPTYSBIO, INC | Faga Daniel | Pres, CEO, Dir | M - OptEx | — | +26.8K | 493.6K | +6% | — |
| D | 2026-01-09 | 2026-01-08 | ANAB | ANAPTYSBIO, INC | Faga Daniel | Pres, CEO, Dir | S - Sale+OE | $44.71 | -14.3K | 479.3K | -3% | -$638.5K |
| D | 2026-01-08 | 2026-01-06 | ANAB | ANAPTYSBIO, INC | Faga Daniel | Pres, CEO, Dir | M - OptEx | — | +17.9K | 476.0K | +4% | — |
| D | 2026-01-08 | 2026-01-07 | ANAB | ANAPTYSBIO, INC | Faga Daniel | Pres, CEO, Dir | S - Sale+OE | $45.11 | -9,202 | 466.8K | -2% | -$415.1K |
| D | 2026-01-06 | 2026-01-03 | ANAB | ANAPTYSBIO, INC | Faga Daniel | Pres, CEO, Dir | M - OptEx | — | +34.7K | 473.4K | +8% | — |
| D | 2026-01-06 | 2026-01-05 | ANAB | ANAPTYSBIO, INC | Faga Daniel | Pres, CEO, Dir | S - Sale+OE | $43.26 | -15.3K | 458.1K | -3% | -$662.3K |
| DM | 2025-01-07 | 2025-01-03+ | ANAB | ANAPTYSBIO, INC | Faga Daniel | Pres, CEO, Dir | F - Tax | $14.83 | -19.4K | 436.5K | -4% | -$288.0K |
| DM | 2025-01-07 | 2025-01-03+ | ANAB | ANAPTYSBIO, INC | Faga Daniel | Pres, CEO, Dir | M - OptEx | — | +52.5K | 442.9K | +13% | — |
| M | 2024-03-26 | 2024-03-22+ | ANAB | ANAPTYSBIO, INC | Faga Daniel | CEO, Dir | S - Sale | $22.75 | -148.9K | 749.1K | -17% | -$3.39M |
| 2024-03-26 | 2024-03-26 | ANAB | ANAPTYSBIO, INC | Faga Daniel | CEO, Dir | F - Tax | $21.60 | -347.4K | 401.6K | -46% | -$7.50M | |
| D | 2024-01-09 | 2024-01-08 | ANAB | ANAPTYSBIO, INC | Faga Daniel | CEO, Dir | S - Sale+OE | $21.81 | -6,866 | 898.0K | -0.8% | -$149.7K |
| D | 2024-01-09 | 2024-01-06 | ANAB | ANAPTYSBIO, INC | Faga Daniel | CEO, Dir | M - OptEx | $0.00 | +17.9K | 904.9K | +2% | $0 |
| 2022-03-23 | 2022-03-21 | ANAB | ANAPTYSBIO, INC | Faga Daniel | Interim CEO, Dir | A - Grant | $0.00 | +887.0K | 887.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations